tiprankstipranks
MannKind to Establish Boston-Area Research & Development Foothold and Expand Portfolio of Dry Powder Inhalation Technology in Transaction With Pulmatrix
PremiumPress ReleasesMannKind to Establish Boston-Area Research & Development Foothold and Expand Portfolio of Dry Powder Inhalation Technology in Transaction With Pulmatrix
2M ago
MannKind to in-license iSPERSE technology from Pulmatrix
PremiumThe Fly
MannKind to in-license iSPERSE technology from Pulmatrix
2M ago
Pulmatrix enters cross license agreement with MannKind
PremiumThe Fly
Pulmatrix enters cross license agreement with MannKind
2M ago
MannKind Corporation to Hold 2024 First Quarter Financial Results Conference Call on May 8, 2024
PremiumPress ReleasesMannKind Corporation to Hold 2024 First Quarter Financial Results Conference Call on May 8, 2024
3M ago
MannKind to proceed with Phase 1 Nintedanib Dpi (Mnkd-201) study
PremiumThe Fly
MannKind to proceed with Phase 1 Nintedanib Dpi (Mnkd-201) study
3M ago
MannKind to Proceed With Phase 1 Nintedanib Dpi (Mnkd-201) Study for Pulmonary Fibrotic Diseases
PremiumPress Releases
MannKind to Proceed With Phase 1 Nintedanib Dpi (Mnkd-201) Study for Pulmonary Fibrotic Diseases
3M ago
MannKind repays certain debt obligations
PremiumThe FlyMannKind repays certain debt obligations
3M ago
MannKind Repays Certain Debt Obligations
PremiumPress Releases
MannKind Repays Certain Debt Obligations
3M ago
MannKind Corp Announces CFO Transition and New Compensation Plan
PremiumCompany Announcements
MannKind Corp Announces CFO Transition and New Compensation Plan
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100